Vanguard Group Inc Cara Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,248,911 shares of CARA stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,248,911

Previous 2,250,334 0.06%

Holding current value

$11.7 Million

Previous $585,000 19.15%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.26 - $0.38 $369 - $540	-1,423 Reduced 0.06%	2,248,911 $697,000
Q2 2024 Aug 13, 2024	SELL	$0.24 - $0.92 $55,421 - $212,450	-230,924 Reduced 9.31%	2,250,334 $585,000
Q1 2024 May 10, 2024	SELL	$0.52 - $1.05 $77,900 - $157,299	-149,809 Reduced 5.69%	2,481,258 $2.26 Million
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $19,570 - $53,819	32,618 Added 1.26%	2,631,067 $1.95 Million
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $7,466 - $14,888	4,471 Added 0.17%	2,598,449 $4.37 Million
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $1.5 Million - $2.61 Million	-528,848 Reduced 16.93%	2,593,978 $7.34 Million
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $103,188 - $258,921	21,102 Added 0.68%	3,122,826 $15.3 Million
Q4 2022 Feb 10, 2023	SELL	$8.88 - $12.77 $1.83 Million - $2.63 Million	-206,127 Reduced 6.23%	3,101,724 $33.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $331,223 - $504,874	40,197 Added 1.23%	3,307,851 $31 Million
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $173,413 - $322,153	23,277 Added 0.72%	3,267,654 $29.8 Million
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $2.1 Million - $2.68 Million	211,615 Added 6.98%	3,244,377 $39.4 Million
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $262,365 - $396,939	21,882 Added 0.73%	3,032,762 $36.9 Million
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $3.07 Million - $4.27 Million	265,783 Added 9.68%	3,010,880 $46.5 Million
Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $34 Million - $80.1 Million	2,745,097 New	2,745,097 $39.2 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $280M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cara Therapeutics, Inc. Transaction History